Form 4 for PCRX Pacira BioSciences, Inc.
Accepted 2024-01-04 00:00:00 ET · period of report 2024-01-02 · accession 0001396814-24-000014 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-01-04 | 2024-01-02 | PCRX | RIKER LAUREN | SVP, Fin | F - Tax | $32.00 | -159 | 22.5K | -0.7% | -$5,088 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-02 | F | D | 159 | $32.00 | 22,528.34 | D | — | — |